Skip to main content
medical check-up

Can Further Tests Be Needed After a Health Check-Up?

September 24, 2026 | 5 min read

A health check-up, commonly known as a check-up, is based on a set of biological analyses and imaging examinations designed to assess the essential functions of the body and to detect potential risk factors at an early stage. However, a standard check-up is not intended to provide a definitive diagnosis for every condition it is designed to identify abnormalities at a screening level. This is why, when certain parameters fall outside or at the boundary of reference values, it is entirely common for the doctor to prescribe additional investigations. The need for further tests does not in any way mean that the initial check-up was insufficient; on the contrary, it demonstrates that the screening process has functioned correctly by identifying a warning sign at the appropriate time.

Contact Us

The further tests prescribed following a health check-up vary considerably depending on the patient's age, sex, family history, and the abnormalities identified. For example, elevated liver enzymes may lead to hepatitis serology and an abdominal ultrasound, whilst a thyroid hormone imbalance may warrant a thyroid ultrasound and an expanded hormonal panel. This referral process forms an integral part of the clinical pathway aimed at establishing a comprehensive and coherent diagnosis. It is therefore essential that anyone who has undergone a health check-up has their results interpreted by a qualified doctor and completes the recommended further tests without delay.

In Which Cases Are In-Depth Investigations Prescribed?

The presence of abnormal biochemical markers in the blood tests is the most common reason for prescribing further investigations. When fasting blood glucose falls within the prediabetic range, an oral glucose tolerance test or a glycated haemoglobin measurement is requested. If the full blood count reveals significant deviations in white blood cells, haemoglobin, or platelets, a blood film, an iron studies panel, or, where appropriate, a bone marrow assessment may be considered. Similarly, elevated creatinine and urea levels in the kidney profile may necessitate the calculation of the glomerular filtration rate and, if needed, a nephrology referral.

Abnormalities detected through imaging examinations are also among the main reasons prompting more detailed investigations. The discovery of a suspicious opacity on a chest radiograph may lead to a chest CT scan, whilst a poorly defined lesion in the liver or kidney on abdominal ultrasound may require MRI with contrast agent injection. In cases of borderline elevation of certain tumour markers, targeted imaging of the organ in question, or even a biopsy, may prove indispensable. All of these decisions are based not on an isolated result but on a comprehensive analysis of the patient's clinical picture, with a constant concern for striking a balance between avoiding unnecessary tests and ensuring early diagnosis.

How Are Uncertain Results Clarified?

The first step in clarifying uncertain or borderline results is to repeat the analysis after a certain interval. A value slightly outside the normal range on a single measurement may be linked to transient physiological factors such as dehydration, intense physical activity, lack of sleep, or the diet followed before the sample was taken. This is why the doctor generally recommends a repeat test within two to four weeks in the case of a minor abnormality. If the values return to normal on the second sample, no further investigation is necessary; if, however, the abnormality persists or worsens, more specific diagnostic tests are scheduled.

As a second step, the specific analyses carried out depend on the condition suspected. In cases of persistently elevated liver enzymes, a panel of viral serology, autoantibody testing, and, where needed, a liver biopsy are considered. In male patients with a PSA level in the borderline range, the ratio of free PSA to total PSA is calculated and a multiparametric MRI of the prostate may be planned. When a thyroid nodule is suspected on ultrasound, a fine-needle aspiration is performed for cytological examination. This stepwise approach protects the patient from unnecessary invasive procedures whilst ensuring that no serious condition goes undetected, thereby allowing therapeutic management to begin as promptly as possible.

Are Further Tests Included in the Health Check-Up?

Standard health check-up packages are based on a predefined list of tests and clinical examinations, the content of which varies according to the healthcare facility's offering. Basic packages generally include a full blood count, a biochemical panel, a urine analysis, a thyroid profile, an electrocardiogram, and a frontal chest radiograph, whilst more comprehensive packages may include tumour markers, an exercise stress test, an echocardiogram, and an abdominal ultrasound. However, the additional investigations prompted by an abnormality discovered during the check-up are not part of the initial package and fall under a separate diagnostic process. This distinction is explained by the very nature of the health check-up, which constitutes a screening programme, whereas the diagnostic confirmation process belongs to a subsequent clinical stage.

The financial aspect of further tests is also a frequent concern among patients. For individuals with supplementary health insurance, all or part of the additional investigations may be covered depending on the terms of the policy, whilst tests prescribed within a coordinated care pathway are largely reimbursed by the statutory health insurance system. It is recommended, before undergoing a health check-up, to enquire with the facility about the exact content of the chosen package and the pricing policy applied in the event of further tests, in order to limit any uncertainty. As the primary purpose of screening is early diagnosis, it is of paramount importance not to delay further tests for financial reasons, as any postponement can have a direct impact on the effectiveness of therapeutic management.